Compounds > pravastatin
Page last updated: 2024-08-23

pravastatin and Cardiomyopathies

pravastatin has been researched along with Cardiomyopathies in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiba, K; Furihata, T; Kameyama, Y; Kobayashi, K; Matsumoto, S; Morimoto, K; Ohishi, T; Satoh, N; Ugajin, M; Yamashita, K1
Alhaj, MA; Elnakish, MT; Hassanain, HH; Hassona, MD; Janssen, PM; Khan, M; Moldovan, L1
Ichihara, K1
Chang, CI; Chao, YC; Chen, HH; Chen, JJ; Cheng, CF; Chiu, TH; Juan, SH; Lian, WS; Lin, H; Lu, CY1
Gross, W; März, W; Müller, HM; Olbrich, HG; Siekmeier, R; Wieland, H1
Cittadino, M; Coelho, OR; Coelho-Filho, OR; De Luca, IM; Hyslop, S; Moreno Júnior, H; Sampaio, RC; Tanus-Santos, JE1

Reviews

1 review(s) available for pravastatin and Cardiomyopathies

ArticleYear
[Myocardial dysfunction].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2006, Volume: 127, Issue:6

    Topics: Animals; Cardiomyopathies; Clinical Trials as Topic; Coenzymes; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Stunning; Myocardium; Oils; Pravastatin; Simvastatin; Solubility; Ubiquinone; Water

2006

Other Studies

5 other study(ies) available for pravastatin and Cardiomyopathies

ArticleYear
Functional analysis of a mutation in the SLCO1B1 gene (c.1628T>G) identified in a Japanese patient with pravastatin-induced myopathy.
    The pharmacogenomics journal, 2009, Volume: 9, Issue:3

    Topics: Base Sequence; Blotting, Western; Cardiomyopathies; Cell Line; DNA Primers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Liver-Specific Organic Anion Transporter 1; Microscopy, Confocal; Mutagenesis, Site-Directed; Mutation; Organic Anion Transporters; Pravastatin

2009
Rac-induced left ventricular dilation in thyroxin-treated ZmRacD transgenic mice: role of cardiomyocyte apoptosis and myocardial fibrosis.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Animals; Apoptosis; Blotting, Western; Carbazoles; Cardiomegaly; Cardiomyopathies; Carvedilol; Echocardiography; Female; Fibrosis; Male; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Pravastatin; Propanolamines; rac GTP-Binding Proteins; Thyroxine; Vasodilator Agents

2012
Pravastatin attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress associated apoptosis.
    Apoptosis : an international journal on programmed cell death, 2008, Volume: 13, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carboplatin; Cardiomyopathies; Carrier Proteins; Caspases; Cells, Cultured; Enzyme Activation; Heart; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Leukopenia; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Oxidative Stress; Pravastatin; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species

2008
Effects of lovastatin and pravastatin on the survival of hamsters with inherited cardiomyopathy.
    Journal of cardiovascular pharmacology and therapeutics, 2000, Volume: 5, Issue:4

    Topics: Administration, Oral; Animals; Anticholesteremic Agents; Cardiomyopathies; Cricetinae; Disease Models, Animal; Female; Lovastatin; Male; Pravastatin; Sex Factors; Survival Analysis; Ubiquinone

2000
Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats.
    International journal of cardiology, 2001, Volume: 79, Issue:2-3

    Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Cardiomyopathies; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Necrosis; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitrites; Pravastatin; Rats; Rats, Wistar; Thromboxane B2

2001